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Introduction
Apnoea is the most prevalent respiratory disorder attributed to the immaturity of the respiratory control system in newborn infants, and caffeine, a methylxanthine derivative, is widely used to treat apnoea (as reviewed recently; Bairam et al. 2015; Di Fiore et al. 2016; Kouchi et al. 2017) . It has been proposed that progesterone or progestin drugs, known to be potent respiratory stimulants, could be used as an alternative (or in addition) to caffeine when apnoeas are resistant to xanthine therapy (Finer et al. 2006) . However, several important concerns about the underlying mechanisms and potential interactions of progesterone with caffeine (Uppari et al. 2016) remain to be investigated before a clinical role could be developed further.
The idea that progesterone could be used for the treatment of apnoea in the newborn is based on the fact that in women after menopause, or in men, it significantly decreases sleep-disordered breathing (Boukari et al. 2017; Lozo et al. 2017) , and increases ventilation in adult subjects (including humans) in normoxic, hypoxic and hypercapnic conditions (Behan & Kinkead, 2011; Boukari et al. 2017; Lozo et al. 2017) . However, we have obtained contradictory data in newborn rats, and the respiratory function of progesterone during postnatal development remains to be elucidated fully. For instance, acute administration of progesterone (4 mg kg −1 , I.P.) in 12-dayold male rats enhances the frequency of apnoea and does not modify minute ventilation in normoxia or in response to hypoxia (Bairam et al. 2013) . These results contrasted with previous studies showing that chronic exposure to progesterone through the lactating dam between postnatal days (P) 2 and 10 decreases the frequency of apnoeas in normoxia and hypoxia and increases the hypoxic ventilatory response, without any effects on minute ventilation in normoxia (Lefter et al. 2007) .
A potential mechanism explaining the enhanced apnoea frequency in newborn rats with acute administration of progesterone is that in the CNS, progesterone is rapidly converted to allopregnanolone, a potent allosteric modulator of the GABA A receptor (Melcangi et al. 2016) , which inhibits ventilation and reduces the excitability of respiratory neurons in the ventrolateral medulla in newborn rats (Ren & Greer, 2006) . We thus sought to determine whether the conversion of progesterone to allopregnanolone masks some of the respiratory effects after an acute injection of progesterone. To address this hypothesis, we used finasteride, a blocker of 5α-reductase, the enzyme converting progesterone to allopregnanolone. We injected finasteride alone or combined with progesterone in male and female rats between the age of P10 and P12.
Another approach to address this question is to use specific agonists to activate progesterone receptors acutely without the confounding effects of allopregnanolone. Members of the nuclear and membrane progesterone receptors (nPR and mPR, respectively) are expressed in the hypothalamus (Bayliss et al. 1990 ) and in dorsal brainstem nuclei involved in respiratory control (Haywood et al. 1999; Boukari et al. 2015 Boukari et al. , 2016 . Nuclear progesterone receptors are also expressed in peripheral chemoreceptors (Joseph et al. 2006 ), but we do not yet know whether mPRs are expressed at this level. Recent data have established that in adult or newborn mice, nPR and mPR are involved in respiratory control. Compared with wild-type, in adult nPR knockout female mice the frequency of apnoeas is increased (Marcouiller et al. 2014) , whereas this effect is not found in males (Boukari et al. 2017) , and mPRβ appears to play a prominent role in respiratory regulation in adult male and female mice (Boukari et al. 2016) . Accordingly, we used specific agonists for nPR (R5020) or mPR (Org OD-02-0) to investigate whether activation of these receptors could reduce the frequency of apnoeas in newborn male and female rats.
To expand our investigations of the sex-specific effects of progesterone in newborn rats, we added a group of rats chronically treated with progesterone. Interestingly, our results indicated that chronic progesterone treatment reduces the frequency of apnoeas more efficiently in males than in females. Given that caffeine decreases apnoea frequency in preterm neonates, and will certainly remain a gold standard, we finally asked whether an acute injection of caffeine in rats chronically treated with progesterone would further decrease the frequency of apnoeas to a similar extent in males and females. Our results indicate that in newborn rats the effects of progesterone on the regulation of breathing are determined by a balance between several pathways mediated on the one hand by allopregnanolone and on the other hand by the different types of progesterone receptors. These results might have clinical importance in the design of complementary strategies to reduce apnoea frequency in preterm neonates.
Methods

Ethical approval
All experiments were conducted in accordance with the guidelines of the Canadian Council on Animal Care, and V. Joseph and others our institutional animal care committee approved the protocols (reference 2012-269).
Animals
We performed our experiments in 10-to 12-day-old male (n = 94) and female (n = 90) Sprague-Dawley rats. All pups were born from virgin females mated with males (1/1) in our animal care facility. Rats were supplied with food and water ad libitum and maintained in standard animal care conditions (21°C, 12 h-12 h dark-light cycle).
Twenty-four hours after birth, litters were culled to 12 pups, with a similar number of males and females if possible. After completing the respiratory recordings, pups with their mother were killed with an overdose of ketamine 200 mg kg −1 and xylazine 20 mg kg −1 (0.2 ml/10 g, I.P.).
Drug preparation and gavage procedure
All drugs used in this study were freshly prepared on the day of the experiment. Finasteride, the inhibitor of 5α-reductase, and progesterone were purchased from Sigma Aldrich (Oakville, ON, Canada, catalogue no. F1293 and P0130), the nPR agonist (promegestone, R5020) was purchased from PerkinElmer (Woodbridge, ON, Canada, catalogue no. NLP0040), and the mPR agonist (10-ethenyl-19-norprogesterone, Org-OD-02-0) from Axon Medchem (Reston, VA, USA, catalogue no. 2085). Progesterone was dissolved in saline and used at 4 mg kg −1 based on previous dose-response curve studies (Hichri et al. 2012) . At this dose in P12 rats, circulating progesterone concentrations increase two to three times, and plasma allopregnanolone is also significantly elevated compared with rats receiving a control injection (Bairam et al. 2013; Uppari et al. 2016) . Finasteride (10 mg kg −1 , I.P.; see Uppari et al. 2016) , nPR and mPR (each at 4 mg kg −1 ) receptor agonists were dissolved in 2% DMSO and 10% cyclodextrin. Control rats received an injection (I.P.) of either saline or vehicle (DMSO plus cyclodextrine) of equivalent volume.
Chronic exposure to progesterone was done by gavage. Gavaging is a routine procedure in our laboratory that we regularly use to determine the long-term effects of drugs in newborn rats (Julien et al. 2011; Uppari et al. 2016) . For these experiments, progesterone was given at 4 mg kg −1 once a day between 08.00 and 09.00 h between postnatal days 3 and 12 [gavage volume: 0.05 ml (10 g body weight)
−1 ]. On the day of the recording, each rat received a single (I.P.) injection of either saline or caffeine (10 mg kg −1 ; Sandoz, Boucherville, QC, Canada). This caffeine dose generates a plasma caffeine concentration of 15.4 ± 2.8 mg l −1 (range 8.7-24.1 mg l −1 ; Julien et al. 2010) , matching the therapeutic level in premature infants (Bairam et al. 1987; Schoen et al. 2014) . As a control control, rats were gavaged with water [0.05 ml (10 g body weight)
−1 ] and received a single injection (I.P.) of saline on the recording day.
Respiratory recording and data collection
We used whole-body flow-through plethysmography (Emka technologies, Paris, France), as previously described in newborn rodents (Lefter et al. 2007; Julien et al. 2010; Potvin et al. 2014; Uppari et al. 2016) . Briefly, fresh air flowing through the chamber was set at 180 ml min −1 , and the temperature inside the chamber was maintained at 30°C using a temperature control system (TCAT-2; Physitemp, Clifton, NJ, USA). The system was calibrated by injecting 0.5 ml air into the chamber. Barometric pressure, chamber temperature and water vapour pressure were continuously recorded, and the rectal temperature of each pup was measured at the beginning of the recording (after 10-15 min in the chamber). These values were used to calculate the tidal volume using the equation described by Bartlett & Tenney (1970) . The respiratory frequency (f R ) and the corrected tidal volume (V T ) were then used to calculate minute ventilation (V E = f R × V T , in millilitres per minute per 100 grams). Oxygen, CO 2 and water pressure levels in the inflow and outflow gas lines were measured with dedicated gas analysers (S3-A/II, CD3A, AEI Technologies; and RH-300, Sable Systems International), allowing the measurement of O 2 consumption (V O 2 ), CO 2 production (V CO 2 ), the O 2 convection ratio (V E /V O 2 ) and the CO 2 convection ratio (V E /V CO 2 ). Details on the formula used for all these calculations are as previously described (Bairam et al. 2013; Ballot et al. 2015; Uppari et al. 2016) . All signals were recorded using Spike2 software (Cambridge Electronic Design, Cambridge, UK) and stored on a computer for further analyses.
Protocol and data analyses
All recordings were performed between 09.00 and 16.00 h. Each rat was first weighted and then introduced to the plethysmography chamber for at least 20-30 min of habituation before receiving an I.P. injection of tested drug or its solvent (saline or vehicle). Between 20 and 30 min after the injection, the respiratory recordings were started when breathing was regular and the pup was calm. Based on previous experiments in newborn rodents, the animals are asleep during such periods (Balbir et al. 2008) . Breathing was recorded in normoxia (basal breathing, 21% O 2 , 20-30 min). We selected portions of stable breathing pattern with the lowest respiratory frequency for a total of 10 min to calculate breath by breath the tidal volume, respiratory frequency and minute ventilation. The same portions were used to assess the frequency of spontaneous and post-sigh apnoeas. Spontaneous apnoeas are defined as an interruption of breathing for a duration 150 (24) 158 (25) 145 (21) 164 (22
38 (11) 37 (15) 34 (12) 29 (16
56 (18) 52 (12) 54 (17) 52 (14) Abbreviations: f R , respiratory frequency;V CO 2 , CO 2 production rate;V E , minute ventilation;V E /V O 2 andV E /V CO 2 , respiratory exchange ratio for O 2 and CO 2 , respectively;V O 2 , O 2 consumption rate; and V T , tidal volume. Values are means (SD). Grey cells indicate that the ANOVA shows a significant effect of progesterone injection (as indicated in the text). Results of the post hoc analysis: * P < 0.05 and * * * P < 0.001, progesterone versus saline in males or females; 0.06 indicates a P value slightly above the threshold of 0.05.
exceeding two normal breaths, and post-sigh apnoeas are immediately preceded by a profound inspiration (at least twice the normal tidal volume) and rapid expiration, as previously described (Lefter et al. 2007; Julien et al. 2010; Bairam et al. 2013; Uppari et al. 2016) .
Statistical analyses
Initially, we used a two-way ANOVA to test the effects of treatment, sex and the interaction between treatment and sex. When a significant effect or interaction was observed (P < 0.05), we used Fisher's LSD post hoc test to determine whether there were significant differences (P < 0.05) between treatment groups or between sexes. Exact P values for all meaningful results (ANOVA and post hoc analyses) are presented in the text, figures and tables. All analyses were made using Prism software (version 6.0; GraphPad Software, La Jolla, CA, USA).
Results
Effects of acute progesterone on respiratory parameters and apnoea frequency
Body weight, body temperature, respiratory and metabolic variables and the number of rats in each group are presented in Table 1 . Compared with the saline group, acute progesterone injection decreasedV E (ANOVA P value for treatment = 0.01), V T (P = 0.007),V O 2 (P = 0.01) andV CO 2 (P = 0.0001; Table 1) , without a significant effect of sex or an interaction between sex and progesterone injection. There was no effect of acute progesterone injection for respiratory frequency,
The acute injection of progesterone increased the frequency of spontaneous and post-sigh apnoea (P for treatment = 0.0002 and 0.0006, respectively; Fig. 1 ). The post hoc analysis showed a clear effect in male and female rats for spontaneous apnoea, but only in males for post-sigh apnoea. Female rats had a lower frequency of post-sigh apnoea than males after the acute injection of progesterone (P for sex = 0.015). Acute progesterone injection also increased the duration of spontaneous apnoea (P for treatment = 0.0008), with the post hoc analysis showing a significant effect in males but not in females (P for interaction between sex and treatment = 0.076).
Effects of finasteride and progesterone plus finasteride injection in male and female rats
Body weight, body temperature and the number of rats studied in each group are presented in Table 2 . There was no effect of finasteride on respiratory parameters when injected alone, but finasteride decreased theV CO 2 in females (Fig. 2) . When progesterone was injected concomitantly with finasteride, theV E , f R and V T were reduced compared with the animals that received the vehicle injection. Although there was no interaction between sex and treatment for these variables, the post hoc analysis showed significant effects only in females. Finasteride injection reduced the frequency of spontaneous apnoeas in males and females (P for treatment = 0.001) but did not affect the frequency of post-sigh apnoeas or the duration of spontaneous or post-sigh apnoeas (Fig. 3) . When progesterone was injected with finasteride, it did not increase the frequency or duration of apnoea. 
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Effects of nuclear and membrane progesterone receptor agonists in male and female rats
Body weight, body temperature and the number of rats studied in each group are presented in Table 3 . There was no effect of the nPR agonist on theV E , f R or V T . However, it significantly reducedV O 2 in female rats (P value for interaction between sex and treatment = 0.04; Fig. 4 ).
Although there was no significant interaction between sex and treatment (P = 0.4), the mPR agonist reduced f R in female rats when compared with females receiving the vehicle or the nPR agonist. The PR agonists reduced the frequency of apnoeas (P value for treatment <0.0001; Fig. 5 ), and although there was no significant interaction between sex and treatment (P = 0.17), the nPR agonist reduced the frequency of spontaneous apnoeas in males only and not in females. In contrast, the mPR agonist reduced the frequency of spontaneous apnoeas in males and females to a similar extent and decreased the frequency of post-sigh apnoea only in males (P value for interaction between sex and treatment = 0.008). Neither agonist influenced the duration of spontaneous or post-sigh apnoeas (Fig. 5) .
Typical examples of respiratory recordings and apnoea in male rats that received an acute injection of progesterone, finasteride or Org-OD-02-0 (male and female) are presented in Fig. 6 .
Effects of chronic progesterone treatment and caffeine on respiratory parameters and apnoea frequency
After chronic progesterone administration, there was no change of respiratory or metabolic parameters (Table 4) , and the acute injections of caffeine in male and female rats did not change respiratory or metabolic parameters. In contrast to acute progesterone administration, chronic progesterone significantly reduced the frequency of spontaneous apnoea in male rats (Fig. 7) ; this effect was attenuated in female rats (P value for treatment <0.0001, P for interaction between sex and treatment = 0.03), and All data are medians, with boxes extending from the 25th to 75th percentiles, and whiskers at the minimal and maximal values. * P < 0.05, * * P < 0.01 and * * * P < 0.001, acute Prog versus saline.°P < 0.05 females versus males.
females treated with progesterone had a higher frequency of spontaneous apnoea than males (Fig. 7) . The frequency of post-sight apnoea was reduced by chronic progesterone treatment in males but not in females (interaction between sex and treatment = 0.002), which had a higher frequency of post-sigh apnoea than males. After caffeine injection, the frequency of spontaneous apnoea decreased in female rats but not in males (P value for treatment <0.0001, P for interaction between sex and treatment = 0.03; Fig. 7 ) compared with rats gavaged with water or progesterone. Finally, caffeine decreased the duration of post-sigh apnoea (P value for treatment = 0.02), but the post hoc analysis showed a significant effect only in females despite the fact that there was no interaction between sex and treatment (P = 0.75).
Discussion
In this study, we provide evidence that in 10-to 12-day-old rats progesterone modulates the respiratory control Abbreviations:V CO 2 , CO 2 production rate;V E /V O 2 andV E /V CO 2 , respiratory exchange ratio for O 2 and CO 2 , respectively; andV O 2 , O 2 consumption rate. All data are medians, with boxes extending from the 25th to 75th percentiles, and whiskers at the minimal and maximal values. * P < 0.05, * * P < 0.01 and * * * P < 0.001 versus saline. system by acting through different mechanisms, and with different effects. An acute injection of progesterone decreasesV E and increases apnoea frequency, whereas chronic progesterone treatment decreases the frequency of apnoeas without alteringV E . When the conversion of progesterone to allopregnanolone was acutely blocked with finasteride, the frequency of apnoea decreased. Our results also show that an agonist of membrane progesterone receptors can reduce the frequency of apnoeas in male and female rats. Interestingly, male and female rats had different responses after a chronic treatment with progesterone, and after this treatment, an acute injection of caffeine reduced the frequency of apnoeas in females, but not in males, thus showing sex-specific complementary effects of both drugs. Altogether, these results establish that in newborn rats, the frequency of apnoea is determined, in part, by a balance between progesterone and allopregnanolone, and that membrane receptors appear to be an interesting target to reduce the frequency of apnoea in newborn males and females (see Fig. 8 for a schematic summary).
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Methodological considerations with whole-body plethysmography
It is notable that whole-body plethysmography remains an indirect method for the measurement of V T (Zhang et al. 2014) and is prone to errors, particularly when used in newborn animals (Mortola & Frappell, 1998) . We take care to record and measure chamber and rectal temperatures as well as water pressure in the plethysmograph chamber using high-precision tools to obtain a reliable estimate of V T . However, we do not take into account the potential mechanical component, which remains a potential source of noise added to the heating and humidification signal obtained by whole-body plethysmography (Zhang et al. 2014) . It is worth mentioning that in newborn rats or mice, the values reported for V T using our set-up are within the same range as those obtained with direct volume recordings with head-out plethysmography systems (see discussion by Potvin et al. 2014 ).
Sex as a variable in respiratory control studies in newborn rodents
One of the limitations of previous studies on the respiratory effects of progesterone in newborn rats (Lefter et al. 2007; Bairam et al. 2013) was that only males were used. It is, however, important to address potential sex-specific disparities because the expression and function of progesterone receptors are sexually dimorphic in the preoptic areas in fetal and newborn rats (Quadros et al. 2002a,b) , and there are sex-specific effects of progesterone receptor deletion on the hypoxic ventilatory response in newborn mice (Potvin et al. 2014) . Furthermore, in human neonates, mortality linked to Respiratory and metabolic parameters in male and female rats after an acute I.P. injection of vehicle, the nuclear progesterone receptor agonist R5020 or the membrane progesterone receptor agonist Org-Od-02-0 (4 mg kg −1 each) Abbreviations:V CO 2 , CO 2 production rate;V E /V O 2 andV E /V CO 2 , respiratory exchange ratio for O 2 and CO 2 , respectively; andV O 2 , O 2 consumption rate. All data are medians, with boxes extending from the 25th to 75th percentiles, and whiskers at the minimal and maximal values. * P < 0.05 versus vehicle or R5020.
V. Joseph and others respiratory disorders, hypoxia or asphyxia is almost 50% higher in males versus females (Mage & Donner, 2004 Kouchi et al. 2017) and, in line with much-needed efforts to reduce sex-based inequity in health-research protocols (Tannenbaum et al. 2016; Heidari et al. 2017) , respiratory studies in newborns should include males and females.
The stability of the breathing pattern is determined, in part, by a balance between progesterone and allopregnanolone
The circulating concentration of progesterone is high at birth in rats (Bairam et al. 2013 ) and humans of both sexes (Hughes et al. 1979) , and then it abruptly decreases Post-sigh apnoea duration (sec) Inspiration is a downward deviation below the baseline. Note the presence of a sigh, followed a few breaths later by an apnoea (classified here as spontaneous; it does not immediately follow the sigh) in the upper left panel (progesterone, male). Note also the lower respiratory frequency (f R ) reported for a female that received the membrane progesterone receptor agonist. 105 (9) 119 (38) 118 (45) 121 (60) 134 (60) 150 ( 145 (9) 162 (7) 168 (21) 170 (43) 176 (28) 165 (13) V O 2 [ml min −1 (100 g) −1 ] 3.6 (0.9) 3.9 (0.5) 3.5 (1.7) 4.7 (1.5) 4.9 (1.1) 4.1 (1.3) V CO 2 [ml min −1 (100 g) −1 ] 2.5 (0.5) 2.6 (0.4) 2.2 (0.4) 2.6 (0.8) 2.6 (0.6) 2.7 (0.5)
31 (11) 31 (11) 42 (19) 27 (13) 28 (11) 40 (22
43 (9) 46 (11) 52 (14) 45 (10) 52 (17) 55 (17) Abbreviations are as for Table 1 . Values are means (SD).
( Hughes et al. 1979) to reach low values in male and female rats during the first 2 weeks after birth (Dohler & Wuttke, 1974) . Independently of these variations of circulating progesterone, the fetal and neonatal central and peripheral nervous systems express the enzymes necessary for the synthesis of progesterone from cholesterol (Kelleher et al. 2011) and for the conversion of progesterone to its neuroactive metabolite, allopregnanolone, a potent allosteric modulator of GABA A receptors (Reddy, 2010; Melcangi et al. 2014 Melcangi et al. , 2016 . Interestingly, the concentration of allopregnanolone in cortical brain extracts is elevated at birth and between postnatal days 10 and 14 in rats (Carre et al. 2001) , coinciding with the time window during which our experiments have been performed. Furthermore, the plasma concentration of allopregnanolone increases after systemic administration of progesterone in adult (Reddy & Apanites, 2005) and newborn rats (Uppari et al. 2016) , indicating an active and rapid conversion of progesterone to allopregnanolone. Our results show that blocking the conversion of progesterone to allopregnanolone with finasteride (a 5α-reductase inhibitor) decreases the frequency of of spontaneous and post-sigh apnoeas in male and female rats after chronic gavage with water, progesterone (Prog; 4 mg kg day −1 ), or after acute caffeine (caf; 10 mg kg −1 ) injection after chronic progesterone gavage All data are medians, with boxes extending from the 25th to 75th percentiles, and whiskers at the minimal and maximal values. * P < 0.05, * * * P < 0.001 and * * * * P < 0.0001 versus vehicle.°P < 0.05 and°°P < 0.01, females versus males.
apnoeas in male and female rats. When progesterone is injected concomitantly with finasteride, there are no additional effects, but as previously reported in 12-day-old rats (Bairam et al. 2013) , injection of progesterone alone increases the frequency of apnoeas. Overall, this indicates that in normoxic conditions there is an active conversion of progesterone to allopregnanolone that imposes a tonic influence on the breathing pattern, and this is sufficient to elevate the frequency of apnoeas. Our results also strongly suggest that an acute injection of progesterone leads to higher concentrations of allopregnanolone, thereby increasing the frequency of apnoea. One of the intriguing effects reported by our data is the fact that progesterone, with or without finasteride, reduces V T ,V E and metabolic rate. This effect was not reported previously in newborn male rats (Bairam et al. 2013) . However, there was an apparent, but not significant, trend for an effect of progesterone to reduce V T andV E in this previous data set. Given that reproducibility of research findings is an increasing concern when dealing with small data sets (Button et al. 2013) , and because our methods for measuring and reporting these variables have not changed since these previous experiments, we pooled the values of male and female rats for V T ,V E ,V O 2 anḋ V CO 2 to increase the statistical power of our analysis. The results (Fig. 9 ) confirm an effect of progesterone under normoxic condition to reduce V T (P = 0.0012, Student's unpaired t test),V E (P = 0.0072),V O 2 (P = 0.0052) anḋ V CO 2 (P = 0.0003), and the total frequency of apnoea was also clearly increased by progesterone injection. However, when progesterone is injected with finasteride, there is a reduction of V T andV E , most apparent in females. Therefore, the inhibitory effect of progesterone on these values could not be attributed entirely to a GABAaergic effect mediated by allopregnanolone and should involve another pathway.
Roles of membrane and nuclear progesterone receptors in breathing pattern stability
Interestingly, in female rats after the injection of the mPR agonist, there was a reduction ofV O 2 and a trend towards a reduction ofV CO 2 , thus suggesting a potential mechanism explaining the response observed in female rats after the injection of progesterone or progesterone plus finasteride. Most notably, the mPR agonist was highly efficient in reducing the frequency of apnoeas in male and female rats. In contrast, the nPR agonist (R5020) was less efficient and significantly reduced the frequency of apnoeas only in males. We used the mPR agonist Org-OD02-0, or 10-ethenyl-19-norprogesterone, a synthetic progesterone derivative that shows elevated binding activity for mPRα The activity of 5α-reductase determines the conversion of progesterone to allopregnanolone, resulting in increased frequency of apnoeas after an acute injection of progesterone. Activation of the nuclear progesterone receptor (nPR) and the membrane progesterone receptor (mPR) with selective agonists reduces the frequency of apnoeas, with mPR being more efficient than nPR. Sex-specific changes affecting the subunit composition of the GABA A receptor after chronic progesterone treatment might modify its contribution to the frequency of apnoeas. (Kelder et al. 2010) , mPRδ and mPRε (Pang et al. 2013) . Org-OD02-0 also has a high binding capacity on plasma membrane isolated from rat brain, in which mPRβ has a high expression level (Zuloaga et al. 2012) , suggesting that it might also be an mPRβ agonist. Therefore, our results could not discriminate which mPR (among the five mPR family members), could be efficient to reduce the frequency of apnoea, but it is worth mentioning that earlier results showed that reduced expression of mPRβ increased the frequency of apnoeas in adult male and female mice, whereas reduced expression of mPRα did not alter the frequency of apnoeas (Boukari et al. 2016) . This is in line with data showing that mPRβ is expressed at a higher level than mPRα in rodent brain (Zuloaga et al. 2012) . However, as mPRδ and mPRε are also expressed at a high level in the brain (Pang et al. 2013) , it is tempting to speculate that they could also play a role in the regulation of the respiratory control system. The nuclear progesterone receptor is also well distributed in the peripheral and central nervous systems, including brainstem areas involved in respiratory control (Brinton et al. 2008; Quadros & Wagner, 2008; Boukari et al. 2015) , and in the carotid body of adult and newborn rats (Joseph et al. 2006) . Compared with wild-type littermates, in adult nPR knockout mice, the frequency of apnoeas recorded during sleep is elevated in females but not in males (Marcouiller et al. 2014; Boukari et al. 2017) , but in newborns the frequency of apnoea is similar between nPR knockout and wild-type mice (Potvin et al. 2014) . It is thus tempting to suggest that in addition to the Data from the present study and from previous experiments carried out in our laboratory (Bairam et al. 2013; see Discussion) . Abbreviations:V CO 2 , CO 2 production rate; andV O 2 , O 2 consumption rate. * * P < 0.01, * * * P < 0.001 and * * * * P < 0.0001, acute progesterone (prog) versus saline. Total number of animals is indicated in each graph.
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balance between allopregnanolone and progesterone, the regulation of breathing by progesterone is also the result of the activation of different types of receptors, including the nPR and mPR, with an apparent difference between males and females for the nPR.
Contrasting and sex-specific effects of acute versus chronic progesterone
Besides the fact that an acute injection of progesterone increases the frequency of apnoea, our previous results showed that chronic treatment with progesterone (between postnatal days 2 and 10) through the lactating mother was, on the contrary, able to reduce apnoea frequency (Lefter et al. 2007) . Therefore, we sought to replicate a similar experiment with chronic progesterone treatment to ensure that this previous result was a genuine effect. We, however, chose a more direct administration method by performing daily gavage with progesterone, an experimental approach that we have used extensively in our model of caffeine exposure (Uppari et al. 2016) , offering a better control over the ingested dose. In line with our previous findings (Lefter et al. 2007 ), the present results show that chronic treatment with progesterone reduces the frequency of apnoeas, but this effect was more important in males than in females. What could explain the discrepancies between the acute and chronic treatment with progesterone? There is no doubt that the question is highly relevant, but at the present state of our knowledge, we can only speculate about these differences. Nonetheless, two hypotheses could be proposed. First, the balance between the GABAergic/allopregnanolone and progesterone receptor pathways might be shifted by the chronic progesterone treatment, favouring the action of mPR and nPR or reducing the GABAergic influence. However, the expression level of mPRα and mPRβ in the spinal cord or brain of adult mice is similar in males and females and is not affected by progesterone treatment (Labombarda et al. 2010; Meffre et al. 2013) , and in adult female rats the expression level of nPR in the nucleus tractus solitarii is not altered by progesterone treatment (Haywood et al. 1999) . Alternatively, progesterone treatment might alter the subunit composition of the GABA A receptor and increase the expression level of α4 or δ subunits, which changes neuronal responses to GABA A receptor activation (Hsu et al. 2003; Smith et al. 2007; Wable et al. 2015) .
The second hypothesis is that chronic exposure to progesterone activates secondary pathways that contribute to a reduction in the frequency of apnoeas. For example, we previously showed that chronic progesterone reduces the synthesis of dopamine in the carotid bodies of adult female rats and suppresses the inhibitory dopaminergic drive at this level (Joseph et al. 2002) . In newborn rats exposed to progesterone through the lactating mother, a similar effect was reported, probably contributing to a reduction in the frequency of apnoeas (Lefter et al. 2007) . Chronic progesterone exposure might also interact with serotonin and serotonin-dependent plasticity, an important component of stability of the respiratory control system (Behan et al. 2003; Behan & Wenninger, 2008) .
Whatever the mechanisms underlying these effects in newborn rats, they are clearly sex specific, with females showing a less pronounced reduction of apnoea than males after the chronic exposure to progesterone. Although it is difficult to give a firm interpretation, these differences may be related to a sex-specific modulation of GABA A receptor subunit expression. Finally, it is worth mentioning that in female rats chronically exposed to progesterone, caffeine decreases the frequency of apnoeas, but this is not the case in males. This is an interesting observation and suggests that caffeine could potentially complement progesterone treatment to reduce the frequency of apnoea in newborn females, and put further emphasis on the necessity to assess sex-specific effects of pharmacological treatments aiming to reduce apnoea frequency (see also Kouchi et al. 2017) . Interestingly, chronic caffeine administration in newborn rats upregulates inhibitory responses of GABA A receptors to progesterone or allopregnanolone, and this effect was also sex specific, being more important in males (Uppari et al. 2016 ) than in females .
Conclusion
We conclude from these studies that the effects of progesterone on respiratory regulation in newborn rats result from the interplay of several pathways that include the conversion of progesterone to allopregnanolone, and the expression of nPR and mPR in central and peripheral areas involved in respiratory control. Although it has been suggested that progesterone or progestin drugs could be used for the treatment of apnoea in preterm neonates when caffeine therapy is not sufficient (Finer et al. 2006) , our results show that we need an in-depth understanding of these different pathways to propose innovative strategies. It is also tempting to speculate that other chronic conditions relevant for neonates (chronic or intermittent hypoxia) might also affect this balance, further underlying the need to document these effects.
